This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Genzyme Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jiaming Shi: Innovator in Pharmaceutical Development
Introduction
Jiaming Shi is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy and safety of medications.
Latest Patents
Jiaming Shi holds a patent for a novel crystalline form of Tolebrutinib. This patent, which is referred to as “Compound I,” encompasses preparation methods, pharmaceutical compositions containing the crystalline form, and its applications in developing BTK inhibitor drugs and treatments for multiple sclerosis. This innovation represents a crucial advancement in the treatment of these conditions.
Career Highlights
Jiaming Shi is currently employed at Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His role at Genzyme allows him to leverage his expertise in pharmaceutical development to contribute to groundbreaking treatments.
Collaborations
One of his notable collaborators is Minhua Chen, with whom he has worked closely on various projects. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical industry.
Conclusion
Jiaming Shi's contributions to pharmaceutical innovation, particularly through his patent on Tolebrutinib, highlight his role as a key figure in advancing medical treatments. His work continues to impact the field positively, paving the way for new therapeutic options.